Advances in Medicine (AIM) 2025

24 May 2025 - 25 May 2025

CGRP-targeted therapies herald a new era in migraine management

14 Jul 2025 by

Calcitonin gene–related peptide (CGRP)–targeted therapies are likely to become a mainstay of migraine headache treatment in the coming decades as they have demonstrated efficacy for acute and preventive treatment, according to Dr Yi-Jing Zhao of Mount Elizabeth Hospital, Singapore, who spoke at AIM 2025.

14 Jul 2025

Diagnosing transient loss of consciousness: Approach to a common clinical conundrum

04 Jul 2025 by

Over 90 percent of transient loss of consciousness (TLOC) presentations are due to syncope, seizure or psychogenic causes, but up to 30 percent of them are misdiagnosed initially due to significant overlap in manifestations, according to Dr Charlie Chan of the Prince of Wales Hospital, who shared tips on diagnosis at AIM 2025.

04 Jul 2025

Blood-based biomarkers may aid earlier diagnosis of Alzheimer’s disease

01 Jul 2025 by

Blood-based biomarkers (BBBs) may potentially aid earlier detection of Alzheimer’s disease (AD) following a recent revision of diagnostic criteria supporting core biomarker–based diagnosis. Initial local experience with lecanemab, a disease-modifying therapy (DMT) for patients with mild cognitive impairment or mild dementia due to AD, was shared at Advances in Medicine (AIM) 2025.

01 Jul 2025